Lipopeptide Antibacterial [EPC]

9504 reported adverse events

Drugs of this class: DAPTOMYCIN DAPTOMYCIN IN SODIUM CHLORIDE

These side effects are most commonly reported by patients taking drugs of the Lipopeptide Antibacterial [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 768
1 OFF LABEL USE 703
2 ACUTE KIDNEY INJURY 628
3 EOSINOPHILIC PNEUMONIA 489
4 PYREXIA 481
5 RHABDOMYOLYSIS 389
6 EOSINOPHILIA 387
7 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 344
8 BLOOD CREATINE PHOSPHOKINASE INCREASED 329
9 PRODUCT USE IN UNAPPROVED INDICATION 321
See all common reactions for Lipopeptide Antibacterial [EPC]

Drugs of the Lipopeptide Antibacterial [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MINIMUM INHIBITORY CONCENTRATION 24 0.7273
1 ABIOTROPHIA DEFECTIVA ENDOCARDITIS 4 0.4444
2 PROTOTHECOSIS 24 0.2553
3 AORTOENTERIC FISTULA 13 0.2031
4 EOSINOPHILIC PNEUMONIA ACUTE 149 0.1721
5 EOSINOPHILIC PNEUMONIA 489 0.1550
6 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 47 0.1521
7 BAND NEUTROPHIL COUNT DECREASED 7 0.1061
8 PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME 15 0.1056
9 INTRACRANIAL INFECTION 13 0.1040
See all enriched reactions for Lipopeptide Antibacterial [EPC]